Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver

被引:82
作者
Loguercio, C [1 ]
De Simone, T
D'Auria, MV
de Sio, I
Federico, A
Tuccillo, C
Abbatecola, AM
Blanco, CD
机构
[1] Univ Naples 2, Sch Gastroenterol, Naples, Italy
[2] Univ Naples 2, Dept Internal Med, Naples, Italy
关键词
non-alcoholic fatty liver disease;
D O I
10.1016/j.dld.2004.01.022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim. To define the characteristics of the Italian patient presenting non-alcoholic fatty liver disease. Patients and methods. A total of 305 patients with abnormally high plasma aminotransferase and/or gamma-glutamyl-transpeptidase levels for at least 12 months, with no known cause of chronic liver damage, were consecutively enrolled in the study. Clinical, routine biochemical and liver histology investigations were carried out in all patients. Also evaluated were: (a) oral glucose load; (b) insulinaemia and insulin-resistance using the HOMA test model; and (c) plasma endotoxaemia, total antioxidant plasma capability, tumour necrosis factor-alpha, plasma interleukin-6 and -10 levels. Malondialdehyde and 4-hydroxynonenal content were determined on liver samples from 120 patients. Results. The majority of patients were young overweight or obese males, with dyslipidaemia (20-60%), diabetes (10.5%), hyperinsulinaemia (40%), hyperferritinaemia (35%). Endotoxaemia was negative in all patients and cytokines were only sporadically altered. Total antioxidant plasma capability was decreased in 38.4% of the patients. Eighty percent of the cases had histological steatosis with a mild degree of inflammation and fibrosis. Seven patients had cirrhosis. Lipid peroxidation markers were increased in 90% of the cases, inversely correlated with fibrosis. Even if at univariate analysis, age, ferritin and tissue 4-hydroxynonenal were independent factors of steatosis (P < 0.01), and insulin, HOMA and ferritin of inflammation and fibrosis (P < 0.01), at multivariate analysis no single factor was found to be an independent predictor of hepatic lesions. Conclusions. The typical Italian patient with non-alcoholic fatty liver disease is a young male, obese, not diabetic, with a variable incidence of dyslipidaemia and hyperinsulinaemia. Only liver biopsy may define the type of liver damage. (C) 2004 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:398 / 405
页数:8
相关论文
共 34 条
[21]  
MCCULLOUGH AJ, 2000, FALK S STEAT NASH AS, P11
[22]   WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance [J].
Melchionda, N ;
Forlani, G ;
Marchesini, G ;
Baraldi, L ;
Natale, S .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (01) :90-96
[23]   THE ROLE OF LIPID-PEROXIDATION IN LIVER-DAMAGE [J].
POLI, G ;
ALBANO, E ;
DIANZANI, MU .
CHEMISTRY AND PHYSICS OF LIPIDS, 1987, 45 (2-4) :117-142
[24]   Nonalcoholic steatohepatitis in children [J].
Rashid, M ;
Roberts, EA .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 30 (01) :48-53
[25]   Nonalcoholic steatohepatitis [J].
Reid, AE .
GASTROENTEROLOGY, 2001, 121 (03) :710-723
[26]   Serum malondialdehyde: Possible use for the clinical management of chronic hepatitis C patients [J].
Romero, MJ ;
Bosch-Morell, F ;
Romero, B ;
Rodrigo, JM ;
Serra, MA ;
Romero, FJ .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 25 (09) :993-997
[27]   The utility of radiological imaging in nonalcoholic fatty liver disease [J].
Saadeh, S ;
Younossi, ZM ;
Remer, EM ;
Gramlich, T ;
Ong, JP ;
Hurley, M ;
Mullen, KD ;
Cooper, JN ;
Sheridan, MJ .
GASTROENTEROLOGY, 2002, 123 (03) :745-750
[28]  
Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572
[29]   Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds [J].
Struben, VMD ;
Hespenheide, EE ;
Caldwell, SH .
AMERICAN JOURNAL OF MEDICINE, 2000, 108 (01) :9-13
[30]   Significance of an index of insulin resistance on admission in non-diabetic patients with acute coronary syndromes [J].
Stubbs, PJ ;
Alaghband-Zadeh, J ;
Laycock, JF ;
Collinson, PO ;
Carter, GD ;
Noble, MIM .
HEART, 1999, 82 (04) :443-447